These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38848201)

  • 1. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Gao F; Wang Y; Li H; Yin J
    Technol Health Care; 2024; 32(5):3083-3095. PubMed ID: 38848201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
    Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
    Rao X; Jiang J; Wang Y; Ma X; Liu S
    Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
    Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
    Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment.
    Zhang Y; Zhou YM; Zhang ZJ; Li X
    Cancer Manag Res; 2020; 12():9077-9085. PubMed ID: 33061602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA-205 as a novel biomarker for cervical cancer patients.
    Ma Q; Wan G; Wang S; Yang W; Zhang J; Yao X
    Cancer Cell Int; 2014; 14():81. PubMed ID: 25788864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
    J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the expression of Stathmin and tumor immune cell infiltration in primary cervical carcinoma and its prognostic diagnostic value.
    Yang H; Li H; Tang X; Zhang J; Zhang X
    Heliyon; 2023 Dec; 9(12):e22585. PubMed ID: 38089980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of miR-153 and miR-203 in patients with cervical cancer and their correlation with human papillomavirus infection.
    Wang Y; Xu B; Shen X; Sun L
    Am J Transl Res; 2021; 13(8):9736-9742. PubMed ID: 34540103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    Zhang Y; Li L; Han Q; Wen L
    J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
    Ma X; Xue H; Zhong J; Feng B; Zuo Y
    Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
    Cui H; Zhang B; Ruan M; Fang C; Li N; Sun X; Qi J; Zuo R; Zhang S; Rong J
    Int J Womens Health; 2022; 14():1037-1045. PubMed ID: 35966402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.
    Jiang D; Yuan X; Ni J; Shen L; Cai M; Xu L
    Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
    Liu P; Xin F; Ma CF
    Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
    BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.